ELV Elevance Health Inc
Price (delayed)
$389.48
Market cap
$88.55B
P/E Ratio
15.09
Dividend/share
$6.52
EPS
$25.81
Enterprise value
$111.49B
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately
Highlights
ELV's P/E is 13% below its last 4 quarters average of 17.9 and 11% below its 5-year quarterly average of 17.4
The company's revenue rose by 3.3% YoY
The equity has decreased by 6% from the previous quarter but it has increased by 5% YoY
Elevance Health's debt has increased by 24% YoY and by 15% from the previous quarter
Elevance Health's net income has decreased by 7% QoQ
Key stats
What are the main financial stats of ELV
Market
Valuations
Earnings
Shares outstanding
227.35M
Market cap
$88.55B
Enterprise value
$111.49B
Price to earnings (P/E)
15.09
Price to book (P/B)
2.19
Price to sales (P/S)
0.51
EV/EBIT
12.25
EV/EBITDA
10.63
EV/Sales
0.63
Revenue
$177.01B
Gross profit
$29.69B
Operating income
$9.09B
Net income
$5.98B
EBIT
$9.1B
EBITDA
$10.49B
Free cash flow
$4.55B
Per share
Balance sheet
Liquidity
EPS
$25.81
EPS diluted
$25.68
Free cash flow per share
$19.63
Book value per share
$178.14
Revenue per share
$763.23
TBVPS
$329.93
Total assets
$116.89B
Total liabilities
$75.46B
Debt
$31.23B
Equity
$41.32B
Working capital
$18.36B
Debt to equity
0.76
Current ratio
1.45
Quick ratio
1.32
Net debt/EBITDA
2.19
Margins
Efficiency
Dividend
EBITDA margin
5.9%
Gross margin
16.8%
Net margin
3.4%
Operating margin
5.1%
Return on assets
5.2%
Return on equity
14.2%
Return on invested capital
16.3%
Return on capital employed
11.9%
Return on sales
5.1%
Dividend yield
1.67%
DPS
$6.52
Payout ratio
25.3%
ELV stock price
How has the Elevance Health stock price performed over time
Intraday
-3.1%
1 week
-0.57%
1 month
-2.86%
1 year
-23.11%
YTD
5.58%
QTD
5.58%
Financial performance
How have Elevance Health's revenue and profit performed over time
Revenue
$177.01B
Gross profit
$29.69B
Operating income
$9.09B
Net income
$5.98B
Gross margin
16.8%
Net margin
3.4%
Elevance Health's net margin has decreased by 8% from the previous quarter and by 2.9% YoY
Elevance Health's net income has decreased by 7% QoQ
The operating margin has declined by 6% since the previous quarter
The operating income has grown by 3.9% YoY but it has contracted by 3.3% from the previous quarter
Growth
What is Elevance Health's growth rate over time
Valuation
What is Elevance Health stock price valuation
P/E
15.09
P/B
2.19
P/S
0.51
EV/EBIT
12.25
EV/EBITDA
10.63
EV/Sales
0.63
ELV's P/E is 13% below its last 4 quarters average of 17.9 and 11% below its 5-year quarterly average of 17.4
Elevance Health's EPS has decreased by 7% QoQ
ELV's price to book (P/B) is 16% lower than its 5-year quarterly average of 2.7 and 16% lower than its last 4 quarters average of 2.7
The equity has decreased by 6% from the previous quarter but it has increased by 5% YoY
ELV's P/S is 24% below its 5-year quarterly average of 0.7 and 24% below its last 4 quarters average of 0.7
The company's revenue rose by 3.3% YoY
Efficiency
How efficient is Elevance Health business performance
Elevance Health's ROIC has decreased by 12% YoY and by 7% from the previous quarter
Elevance Health's return on assets has decreased by 9% QoQ and by 5% YoY
ELV's ROE is down by 9% YoY and by 8% QoQ
Elevance Health's return on sales has decreased by 6% QoQ
Dividends
What is ELV's dividend history
DPS
$6.52
Dividend yield
1.67%
Payout ratio
25.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Elevance Health financials performed over time
The total assets is 55% higher than the total liabilities
The total liabilities is up by 9% year-on-year and by 3.9% since the previous quarter
The total assets rose by 7% YoY
Elevance Health's debt is 24% less than its equity
Elevance Health's debt has increased by 24% YoY and by 15% from the previous quarter
The debt to equity is up by 23% since the previous quarter and by 19% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.